The Rise of Fluoroquinolone-Resistant Escherichia coli in the Community: Scarier Than We Thought.
作者信息
Spellberg Brad, Doi Yohei
机构信息
Los Angeles County-University of Southern California (USC) Medical Center Division of Infectious Diseases, Keck School of Medicine at USC, Los Angeles, California.
Division of Infectious Diseases, University of Pittsburgh Medical Center, Pennsylvania.
出版信息
J Infect Dis. 2015 Dec 15;212(12):1853-5. doi: 10.1093/infdis/jiv279. Epub 2015 May 12.
Abstract
摘要
相似文献
1
The Rise of Fluoroquinolone-Resistant Escherichia coli in the Community: Scarier Than We Thought.社区中耐氟喹诺酮大肠杆菌的出现：比我们想象的更可怕。
J Infect Dis. 2015 Dec 15;212(12):1853-5. doi: 10.1093/infdis/jiv279. Epub 2015 May 12.
2
Gut Colonization of Healthy Children and Their Mothers With Pathogenic Ciprofloxacin-Resistant Escherichia coli.健康儿童及其母亲被致病性耐环丙沙星大肠杆菌肠道定植的情况。
J Infect Dis. 2015 Dec 15;212(12):1862-8. doi: 10.1093/infdis/jiv278. Epub 2015 May 12.
3
Excess body weight and age associated with the carriage of fluoroquinolone and third-generation cephalosporin resistance genes in commensal Escherichia coli from a cohort of urban Vietnamese children.超重和年龄与城市越南儿童人群共生大肠杆菌中氟喹诺酮类和第三代头孢菌素耐药基因的携带有关。
J Med Microbiol. 2018 Oct;67(10):1457-1466. doi: 10.1099/jmm.0.000820. Epub 2018 Aug 16.
4
Within-household sharing of a fluoroquinolone-resistant Escherichia coli sequence type ST131 strain causing pediatric osteoarticular infection.耐氟喹诺酮的大肠杆菌 ST131 序列型菌株在家庭内的传播导致儿科骨关节炎感染。
Pediatr Infect Dis J. 2010 May;29(5):473-5. doi: 10.1097/INF.0b013e3181c89bd7.
5
Rise in ciprofloxacin resistance in Escherichia coli from urinary tract infections from 1999-2004.
Int J Antimicrob Agents. 2005 Jun;25(6):550-1. doi: 10.1016/j.ijantimicag.2005.04.001.
6
Risk factors for the development of gastrointestinal colonization with fluoroquinolone-resistant Escherichia coli in residents of long-term care facilities.长期护理机构居民中发生氟喹诺酮耐药大肠埃希菌胃肠道定植的危险因素。
J Infect Dis. 2014 Feb 1;209(3):420-5. doi: 10.1093/infdis/jit471. Epub 2013 Aug 28.
7
Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.从土耳其社区获得性尿路感染中分离出的大肠杆菌菌株对环丙沙星耐药的危险因素。
J Antimicrob Chemother. 2005 Nov;56(5):914-8. doi: 10.1093/jac/dki344. Epub 2005 Sep 20.
8
Risk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population.老年人群中由大肠杆菌引起的社区获得性尿路感染对环丙沙星耐药的危险因素。
J Antimicrob Chemother. 2017 Jan;72(1):281-289. doi: 10.1093/jac/dkw399. Epub 2016 Sep 21.
9
Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.氟喹诺酮类药物在低使用率国家中的使用量迅速增加期间，从尿路感染致病性大肠埃希菌中分离出的氟喹诺酮类耐药机制。
Microb Drug Resist. 2011 Sep;17(3):395-406. doi: 10.1089/mdr.2011.0015. Epub 2011 Jun 13.
10
Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli.养老院是产超广谱β-内酰胺酶（ESBL）且对环丙沙星耐药的大肠杆菌的储存库。
J Antimicrob Chemother. 2009 Sep;64(3):635-41. doi: 10.1093/jac/dkp220. Epub 2009 Jun 23.
引用本文的文献
1
Clonal and resistance profiles of fluoroquinolone-resistant uropathogenic in countries with different practices of antibiotic prescription.不同抗生素处方习惯国家中耐氟喹诺酮类尿路致病性细菌的克隆及耐药谱
Front Microbiol. 2024 Oct 2;15:1446818. doi: 10.3389/fmicb.2024.1446818. eCollection 2024.
2
Antimicrobial resistance profiles of isolated from clinical and environmental samples: findings and implications.从临床和环境样本中分离出的抗菌药物耐药性概况：研究结果与启示
JAC Antimicrob Resist. 2024 Apr 27;6(2):dlae061. doi: 10.1093/jacamr/dlae061. eCollection 2024 Apr.
3
Longitudinal metagenomic study reveals the dynamics of fecal antibiotic resistome in pigs throughout the lifetime.纵向宏基因组学研究揭示了猪一生中粪便抗生素耐药组的动态变化。
Anim Microbiome. 2023 Nov 8;5(1):55. doi: 10.1186/s42523-023-00279-z.
4
Global impact of antibacterial resistance in patients with hematologic malignancies and hematopoietic cell transplant recipients.血液恶性肿瘤和造血细胞移植受者的抗菌耐药全球影响。
Transpl Infect Dis. 2023 Nov;25 Suppl 1(Suppl 1):e14169. doi: 10.1111/tid.14169. Epub 2023 Oct 20.
5
Increase in the community circulation of ciprofloxacin-resistant Escherichia coli despite reduction in antibiotic prescriptions.尽管抗生素处方量减少，但耐环丙沙星大肠杆菌在社区中的传播仍在增加。
Commun Med (Lond). 2023 Aug 12;3(1):110. doi: 10.1038/s43856-023-00337-2.
6
Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL.利用常规和探索性血清蛋白质组学以及复发/难治性B-NHL患者接受CD19嵌合抗原受体T细胞治疗后的HT10评分识别慢性移植物抗宿主病背景下的早期感染
Hemasphere. 2023 Apr 5;7(4):e858. doi: 10.1097/HS9.0000000000000858. eCollection 2023 Apr.
7
Evolution of Antibiotic Resistance in and Clinical Isolates in a Multi-Profile Hospital over 5 Years (2017-2021).一家综合医院5年（2017 - 2021年）内临床分离株抗生素耐药性的演变
J Clin Med. 2023 Mar 21;12(6):2414. doi: 10.3390/jcm12062414.
8
Increase in the Rate of Gut Carriage of Fluoroquinolone-Resistant Escherichia coli despite a Reduction in Antibiotic Prescriptions.尽管抗生素处方量有所减少，但耐氟喹诺酮大肠杆菌的肠道携带率仍在上升。
Res Sq. 2023 Jan 12:rs.3.rs-2426668. doi: 10.21203/rs.3.rs-2426668/v1.
9
A retrospective review of oral cephalosporins versus fluoroquinolones for the treatment of pyelonephritis.回顾性分析口服头孢菌素与氟喹诺酮类药物治疗肾盂肾炎的效果。
PLoS One. 2022 Sep 9;17(9):e0274194. doi: 10.1371/journal.pone.0274194. eCollection 2022.
10
Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight against Antibacterial Resistance.氟喹诺酮类杂化分子作为对抗抗菌耐药性的有前景的抗菌剂。
Pharmaceutics. 2022 Aug 22;14(8):1749. doi: 10.3390/pharmaceutics14081749.
本文引用的文献
1
Gut Colonization of Healthy Children and Their Mothers With Pathogenic Ciprofloxacin-Resistant Escherichia coli.健康儿童及其母亲被致病性耐环丙沙星大肠杆菌肠道定植的情况。
J Infect Dis. 2015 Dec 15;212(12):1862-8. doi: 10.1093/infdis/jiv278. Epub 2015 May 12.
2
Effect of on-farm use of antimicrobial drugs on resistance in fecal Escherichia coli of preweaned dairy calves.农场使用抗菌药物对断奶前奶牛犊粪便中大肠杆菌耐药性的影响。
J Dairy Sci. 2014 Dec;97(12):7644-54. doi: 10.3168/jds.2014-8521. Epub 2014 Oct 11.
3
The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.产超广谱β-内酰胺酶大肠杆菌 ST131 流行是由一个单一的高致病性亚克隆 H30-Rx 驱动的。
mBio. 2013 Dec 17;4(6):e00377-13. doi: 10.1128/mBio.00377-13.
4
Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.大肠杆菌序列型 131（ST131）子克隆 H30 作为一种新出现的美国退伍军人中多重耐药病原体。
Clin Infect Dis. 2013 Nov;57(9):1256-65. doi: 10.1093/cid/cit503. Epub 2013 Aug 6.
5
Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011.美国住院患者尿标本中产革兰氏阴性杆菌的抗菌药物敏感性：监测抗菌药物耐药性趋势（SMART）研究项目的结果：2009-2011 年。
Clin Ther. 2013 Jun;35(6):872-7. doi: 10.1016/j.clinthera.2013.03.022. Epub 2013 Apr 25.
6
Escherichia coli antimicrobial resistance increased faster among geriatric outpatients compared with adult outpatients in the USA, 2000-10.美国 2000-2010 年期间，老年门诊患者的大肠杆菌对抗菌药物的耐药性增长速度快于成年门诊患者。
J Antimicrob Chemother. 2013 Aug;68(8):1838-41. doi: 10.1093/jac/dkt110. Epub 2013 Apr 4.
7
Trends in susceptibility of selected gram-negative bacilli isolated from intra-abdominal infections in North America: SMART 2005-2010.北美腹腔内感染分离的部分革兰氏阴性杆菌的药敏趋势：SMART 2005-2010 年研究。
Diagn Microbiol Infect Dis. 2013 Jul;76(3):379-81. doi: 10.1016/j.diagmicrobio.2013.02.031. Epub 2013 Mar 27.
8
Epidemiology and susceptibility of Gram-negative appendicitis pathogens: SMART 2008-2010.革兰氏阴性阑尾炎病原体的流行病学和易感性：SMART 2008-2010。
Surg Infect (Larchmt). 2013 Apr;14(2):203-8. doi: 10.1089/sur.2012.034. Epub 2013 Mar 29.
9
Seven ways to preserve the miracle of antibiotics.七种方法保护抗生素这一医学奇迹。
Clin Infect Dis. 2013 May;56(10):1445-50. doi: 10.1093/cid/cit070. Epub 2013 Feb 12.
10
Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States.美国社区获得性产超广谱β-内酰胺酶大肠埃希菌感染。
Clin Infect Dis. 2013 Mar;56(5):641-8. doi: 10.1093/cid/cis942. Epub 2012 Nov 13.
Zotero 插件